Ticker Details
Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
IPO Date:	December 31, 1981
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$136.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 1.09%
Avg Daily Range (30 D):	$0.93 | 1.49%
Avg Daily Range (90 D):	$0.85 | 1.44%

Institutional Daily Volume
Avg Daily Volume:	9.39M
Avg Daily Volume (30 D):	8.82M
Avg Daily Volume (90 D):	8.24M

Trade Size
Avg Trade Size (Sh.):	173
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	131,526
Avg Institutional Trade:	$5.21M
Avg Institutional Trade (30 D):	$9.57M
Avg Institutional Trade (90 D):	$9.43M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	22

Market Closing Trades
Avg Closing Trade:	$59.4M
Avg Closing Trade (30 D):	$146.61M
Avg Closing Trade (90 D):	$148.99M
Avg Closing Volume:	1.11M

News

Aug 14, 2026 @ 7:26 PM AbbVie vs. Bristol-Myers Squibb: Which Healthcare ... Source: Sara Appino

Jul 30, 2026 @ 8:15 PM Johnson & Johnson Just Got FDA Clearance for Its S... Source: Prosper Junior Bakiny

Jul 24, 2026 @ 8:30 PM Is Bristol Myers Squibb's Dividend Too Good to Be ... Source: Justin Pope

Jul 23, 2026 @ 5:00 PM Molecular Glues Clinical Trial Landscape: 80+ Emer... Source: Delveinsight

Jul 22, 2026 @ 9:30 AM Cathie Wood's $362 Million CRISPR Therapeutics Bet... Source: James Brumley

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$4.56	$1.62	$1.32
Diluted EPS	$4.54	$1.62	$1.31
Revenue	$49.19B	$12.97B	$11.49B
Gross Profit	$34.51B	$9.25B	$8.07B
Net Income / Loss	$9.27B	$3.32B	$2.68B
Operating Income / Loss	$11.91B	$4.09B	$3.24B
Cost of Revenue	$14.68B	$3.73B	$3.42B
Net Cash Flow	$-3889M
PE Ratio